Novozymes A/S

(PINK:NVZMF)

Latest On Novozymes A/S (NVZMF):

Date/Time Type Description Signal Details
2024-08-30 06:01 ESTDividendA dividend of $2 has been announced on Aug 29, 2024. It will be paid Sep 3, 2024 with an ex-dividend date of Aug 30, 2024.Neutral
2024-05-01 05:59 ESTDividendA dividend of $2 has been announced on Apr 9, 2024. It will be paid May 3, 2024 with an ex-dividend date of May 1, 2024.Neutral
2023-02-03 04:59 ESTDividendA dividend of $6 has been announced on Jan 26, 2023. It will be paid Mar 7, 2023 with an ex-dividend date of Feb 3, 2023.Neutral
2023-01-26 15:05 ESTNewsNovozymes A/S GAAP EPS of DKK3.18, revenue of DKK4.53BN/A
2022-08-11 19:33 ESTNewsNovozymes A/S GAAP EPS of DKK5.87, revenue of DKK8.66B beats by DKK8.1BN/A
2022-04-27 15:19 ESTNewsNovozymes A/S GAAP EPS of DKK2.98, revenue of DKK4.37BN/A
2022-03-17 05:59 ESTDividendA dividend of $5.5 has been announced on Feb 1, 2022. It will be paid Mar 21, 2022 with an ex-dividend date of Mar 17, 2022.Neutral
2021-03-12 05:03 ESTDividendA dividend of $5.25 has been announced on Nov 30, -0001. It will be paid Mar 16, 2021 with an ex-dividend date of Mar 12, 2021.Neutral
2021-02-05 01:32 ESTFinancialsCompany financials have been released.Neutral
2021-02-03 05:04 ESTEarnings EstimateAn EPS average of $1.88 is estimated for the 2022 year.Buy
2021-02-03 05:04 ESTEarnings EstimateAn EPS average of $0.37 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-02 18:06 ESTNewsNovozymes A/S reports Q4 resultsN/A
2020-11-26 22:48 ESTFinancialsCompany financials have been released.Neutral
2020-11-21 10:03 ESTNewsStocks To Watch: Eyes On Best Buy, Vaccines And Holiday CheerN/A
2020-11-08 01:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:13 ESTFinancialsCompany financials have been released.Neutral
2020-11-02 19:30 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 15:48 ESTEarnings EstimateAn EPS average of $0.45 is estimated for the quarter ending on March 31, 2021.Buy
2020-10-21 10:20 ESTNewsNovozymes A/S reports Q3 resultsN/A
2020-09-26 15:05 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 07:12 ESTFinancialsCompany financials have been released.Neutral
2020-08-15 18:22 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:07 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 05:55 ESTNewsNovozymes A/S reports 1H resultsN/A
2020-08-06 14:43 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 18:51 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 06:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:02 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 14:43 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 19:30 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 10:55 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 18:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 02:26 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 14:33 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 06:38 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:14 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 07:16 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 02:50 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 07:30 ESTFinancialsCompany financials have been released.Neutral
2020-05-02 02:59 ESTNewsNovozymes A/S reports Q1 resultsN/A
2020-05-02 02:59 ESTNewsNovozymes A/S 2020 Q1 - Results - Earnings Call PresentationN/A
2020-05-02 02:58 ESTNewsNovozymes (NVZMF) CEO Ester Baiget on Q1 2020 Results - Earnings Call TranscriptN/A
2020-05-01 18:27 ESTFinancialsCompany financials have been released.Neutral
2020-04-30 10:12 ESTEarnings EstimateAn EPS average of $2.61 is estimated for the quarter ending on September 30, 2020.Sell
2020-04-20 06:16 ESTFinancialsCompany financials have been released.Neutral
2020-04-09 22:21 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 22:50 ESTFinancialsCompany financials have been released.Neutral
2020-03-25 22:22 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 05:55 ESTFinancialsCompany financials have been released.Neutral

About Novozymes A/S (NVZMF):

Novozymes A/S produces and sells industrial enzymes and microorganisms in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers agriculture solutions, including crop production, and animal health and nutrition solutions; liquefaction, saccharifaction, fermentation, cellulosic hydrolysis, and process enhancement solutions for bioenergy; baking, beverages, dairy, starch, and protein ingredients for the food and beverage industry; and laundry, dishwashing, and professional cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising denim abrasion and finishing, biopreparation, biopolishing bleach clean-up, and desizing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rTrypsin for cell culture. Novozymes A/S has collaboration with FMC Corporation to co-develop enzyme solutions. The company is based in Bagsvaerd, Denmark.

NVZMF Quotes by TradingView

See Advanced Chart

General

  • Name Novozymes A/S
  • Symbol NVZMF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorBasic Materials
  • IndustryChemicals
  • Full Time Employees 5,903
  • Last Split Factor5:1
  • Last Split Date2011-11-28
  • Fiscal Year EndDecember
  • Web URLhttp://www.novozymes.com
View More

Valuation

  • Trailing PE 34.22
  • Forward PE 34.13
  • Price/Sales (Trailing 12 Mt.) 7.69
  • Price/Book (Most Recent Quarter) 9.5
  • Enterprise Value Revenue 1.25
  • Enterprise Value EBITDA 3.61
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.71
  • Next Year EPS Estimate $1.85
  • Next Quarter EPS Estimate $0.47
  • Profit Margin 20%
  • Return on Assets 11%
  • Return on Equity 25%
  • Earnings Per Share $1.69
  • Revenue Per Share $0
  • Gross Profit 7.85 billion
  • Quarterly Earnings Growth -7.6%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 27.24
  • Environment Score 13
  • Social Score 10.68
  • Governance Score 11.57
  • Controversy Level 1
View More

Highlights

  • Market Capitalization 16.61 billion
  • PEG Ratio 4.06
  • Analyst Target Price $28.3
  • Book Value Per Share $5.93
View More

Share Statistics

  • Shares Outstanding 225.34 million
  • Shares Float 206.54 million
  • % Held by Insiders 885%
  • % Held by Institutions 40.9%
View More

Technicals

  • Beta 0.26
  • 52 Week High $67.84
  • 52 Week Low $39.35
  • 50 Day Moving Average 62.53
  • 200 Day Moving Average 60.76
View More

Dividends

  • Forward Annual Dividend Rate $0.84
  • Forward Annual Dividend Yield 1.31%
  • Payout Ratio 57%
  • Dividend Date 2018-03-16
  • ExDividend Date 2021-03-12
  • Dividend Per Share $0.84
  • Dividend Yield 0%
View More

Novozymes A/S (NVZMF) Dividend Calendar:

NVZMF's last dividend payment was made to shareholders on March 16, 2018.
Novozymes A/S pays out 57% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2024-08-302024-09-032024-08-302024-08-29$2
2024-05-012024-05-032024-05-022024-04-09$2
2023-10-112023-10-192023-10-120000-00-00$4.2
2023-02-032023-03-072023-02-062023-01-26$6
2022-03-172022-03-212022-03-182022-02-01$5.5
2021-03-122021-03-162021-03-150000-00-00$5.25
2020-02-272020-03-022020-02-28$5.25
2019-02-282019-03-042019-03-012019-02-01$5
2018-03-142018-03-162018-03-150000-00-00$4.5
2017-02-232017-02-272017-02-242017-01-19$4
2016-02-252016-02-292016-02-260000-00-00$3.5

Novozymes A/S (NVZMF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$3.45 billion$0.37$0.41-9.76%
2020-09-302020-12-31$3.43 billion$0.38$2.45-84.4%
2020-06-302020-09-30$N/A$0.40$2.33-82.9%
2020-03-312020-06-30$N/A$0.34$2.79-87.68%
2019-12-312020-03-31$559.96 million$0.43$2.82-84.91%
2019-09-302019-12-31$540.75 million$0.49$2.65-81.55%
2019-06-302019-09-30$522.85 million$0.33$3.42-90.48%
2019-03-312019-06-30$522.87 million$0.48$2.69-82.33%
2018-12-312019-03-31$570.4 million$0.36$2.76-86.88%
2018-09-302018-12-31$568 million$0.44$2.76-83.97%
2018-06-302018-09-30$546.38 million$0.43$2.62-83.6%
2018-03-312018-06-30$581.31 million$0.42$2.57-83.84%
2017-12-312018-03-31$592.26 million$0.45$2.84-84.11%
2017-09-302017-12-31$564.33 million$0.43$2.69-83.94%
2017-06-302017-09-30$543.64 million$0.44$2.59-83.07%
2017-03-312017-06-30$535.7 million$0.38$2.57-85.24%
2016-12-312017-03-31$3.71 billion$0.37$2.59-85.71%
2016-09-302016-12-31$0.38$2.63-85.56%
2016-06-302016-09-30$0.37$2.49-84.97%
2016-03-312016-06-30$0.37$2.43-84.89%
2015-12-312016-03-31$0.37$2.30-83.85%
2015-09-302015-12-31$0.33$2.35-86.06%
2015-06-302015-09-30$0.36$2.37-84.79%
2015-03-312015-06-30$0.33$2.23-85.27%
2014-12-312015-03-31$0.33$1.90-82.82%
2014-09-302014-12-31$0.32$1.92-83.59%
2014-06-302014-09-30$0.34$1.94-82.26%
2014-03-312014-06-30$0.34$1.91-82.02%
2013-12-312014-03-31$0.40$1.71-76.47%
2013-09-302013-12-31$0.32$1.80-81.95%
2013-06-302013-09-30$0.32
2013-03-312013-06-30$0.31
2012-12-312013-03-31$0.28
2012-09-302012-12-31$0.28
2012-06-302012-09-30$0.28
2012-03-312012-06-30$0.26
2011-12-312012-03-31$0.28
2011-09-302011-12-31$0.20
2011-06-302011-09-30$0.29
2011-03-312011-06-30$0.28
2010-12-312011-03-31$0.29
2010-09-302010-12-31$0.20
2010-06-302010-06-30$0.22
2010-03-312010-03-31$0.24
2009-12-312009-12-31$0.19
2009-09-302009-09-30$0.19
2009-06-302009-06-30$0.16
2009-03-312009-03-31$0.17
2008-12-312008-12-31$0.14
2008-09-302008-09-30$0.17
2008-06-302008-06-30$0.19
2008-03-312008-03-31$0.17
2007-12-312007-12-31$0.15
2007-09-302007-09-30$0.14
2007-06-302007-06-30$0.18
2007-03-312007-03-31$0.14
2006-12-312006-12-31$0.13
2006-09-302006-09-30$0.12
2006-06-302006-06-30$0.13
2006-03-312006-03-31$0.10
2005-12-312005-12-31$0.09
2005-09-302005-09-30$0.11
2005-06-302005-06-30$0.12
2005-03-312005-03-31$0.10
2004-12-312004-12-31$0.09
2004-09-302004-09-30$0.11
2004-06-302004-06-30$0.09
2004-03-312004-03-31$0.09
2003-12-312003-12-31$0.09
2003-09-302003-09-30$0.07

Novozymes A/S (NVZMF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Novozymes A/S (NVZMF) Chart:

Novozymes A/S (NVZMF) News:

Below you will find a list of latest news for Novozymes A/S (NVZMF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Novozymes A/S (NVZMF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Novozymes A/S (NVZMF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2007-08-14F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1131345/000114420407042775/0001144204-07-042775-index.htm
2010-03-16F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1131345/000119380510000721/0001193805-10-000721-index.htm
2010-06-02F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1131345/000119380510001584/0001193805-10-001584-index.htm
2017-09-29F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1131345/000119380517002625/0001193805-17-002625-index.htm
2019-11-22F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1131345/000119380519001753/0001193805-19-001753-index.htm
2005-10-25SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999705043717/9999999997-05-043717-index.htm
2005-11-09SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999705045404/9999999997-05-045404-index.htm
2005-10-1812G32BRExemptions for American Depository Receipts and Certain Foreign Securitieshttps://www.sec.gov/Archives/edgar/data/1131345/999999999705045694/9999999997-05-045694-index.htm
2005-10-18ARSAnnual Report to Security Holdershttps://www.sec.gov/Archives/edgar/data/1131345/999999999705045696/9999999997-05-045696-index.htm
2005-10-18ARSAnnual Report to Security Holdershttps://www.sec.gov/Archives/edgar/data/1131345/999999999705045697/9999999997-05-045697-index.htm
2005-12-01SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999705047808/9999999997-05-047808-index.htm
2006-01-04SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706000359/9999999997-06-000359-index.htm
2006-02-06SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706004526/9999999997-06-004526-index.htm
2006-02-24ARSAnnual Report to Security Holdershttps://www.sec.gov/Archives/edgar/data/1131345/999999999706006728/9999999997-06-006728-index.htm
2006-03-06SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706007393/9999999997-06-007393-index.htm
2006-03-13SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706008765/9999999997-06-008765-index.htm
2006-05-08SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706018638/9999999997-06-018638-index.htm
2006-05-18SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706020519/9999999997-06-020519-index.htm
2006-06-21SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706026238/9999999997-06-026238-index.htm
2006-07-31SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706032473/9999999997-06-032473-index.htm
2006-08-18SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706035816/9999999997-06-035816-index.htm
2006-08-22SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706035993/9999999997-06-035993-index.htm
2006-09-05SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706037333/9999999997-06-037333-index.htm
2006-09-05SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706037411/9999999997-06-037411-index.htm
2006-11-07SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706045073/9999999997-06-045073-index.htm
2006-12-07SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706048485/9999999997-06-048485-index.htm
2006-12-21SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999706049730/9999999997-06-049730-index.htm
2007-02-06SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707005493/9999999997-07-005493-index.htm
2007-02-20SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707006589/9999999997-07-006589-index.htm
2007-02-27SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707007788/9999999997-07-007788-index.htm
2007-02-27ARSAnnual Report to Security Holdershttps://www.sec.gov/Archives/edgar/data/1131345/999999999707007927/9999999997-07-007927-index.htm
2007-03-15SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707011876/9999999997-07-011876-index.htm
2007-04-18SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707019518/9999999997-07-019518-index.htm
2007-04-23SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707020129/9999999997-07-020129-index.htm
2007-05-02SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707022154/9999999997-07-022154-index.htm
2007-06-14SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707028299/9999999997-07-028299-index.htm
2007-06-25SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999707029702/9999999997-07-029702-index.htm
2008-02-13SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1131345/999999999708006211/9999999997-08-006211-index.htm
2008-02-25ARSAnnual Report to Security Holdershttps://www.sec.gov/Archives/edgar/data/1131345/999999999708007733/9999999997-08-007733-index.htm
2009-02-24ARSAnnual Report to Security Holdershttps://www.sec.gov/Archives/edgar/data/1131345/999999999709004778/9999999997-09-004778-index.htm